{"title":"Cutaneous and serological profiles of idiopathic inflammatory myopathies in a hispanic population","authors":"Selene Maribel Delgado-Ayala , Sonia Chávez-Álvarez , Jorge Ocampo-Candiani , Miguel Ángel Villarreal-Alarcón , Dionicio Ángel Galarza-Delgado , Lourdes Gil-Flores , David Vega-Morales","doi":"10.1016/j.reumae.2026.502100","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>In the diagnosis and management of idiopathic inflammatory myopathies, cutaneous manifestations are particularly significant. Clinical signs are often associated with specific autoantibodies and play a role in the classification, treatment, and prognosis of IIM.</div></div><div><h3>Objective</h3><div>Describe the cutaneous clinical presentation, phototype, and autoantibody profiles among Hispanic patients with IIM.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted from January 2015 to November 2022, including 64 patients diagnosed with IIM. Rheumatological and dermatological evaluations were performed, assessing Fitzpatrick phototype and Cutaneous Dermatomyositis Activity and Severity Index (CDASI) scores. Autoantibodies were analyzed using immunoblotting.</div></div><div><h3>Results</h3><div>Dermatomyositis (DM) was the most common subtype (73.4%). Fitzpatrick phototypes IV (59.4%) and III (37.5%) predominated. CDASI scores indicated mild dermatological activity in 60.9% of cases. Cluster analysis identified four patient groups with distinct clinical and serological profiles.</div></div><div><h3>Conclusion</h3><div>IIM have a complex disease expression. Recognizing its heterogeneities can enhance personalized treatment approaches.</div></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":"22 3","pages":"Article 502100"},"PeriodicalIF":0.0000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reumatologia clinica","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2173574326000444","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/1 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
In the diagnosis and management of idiopathic inflammatory myopathies, cutaneous manifestations are particularly significant. Clinical signs are often associated with specific autoantibodies and play a role in the classification, treatment, and prognosis of IIM.
Objective
Describe the cutaneous clinical presentation, phototype, and autoantibody profiles among Hispanic patients with IIM.
Methods
A cross-sectional study was conducted from January 2015 to November 2022, including 64 patients diagnosed with IIM. Rheumatological and dermatological evaluations were performed, assessing Fitzpatrick phototype and Cutaneous Dermatomyositis Activity and Severity Index (CDASI) scores. Autoantibodies were analyzed using immunoblotting.
Results
Dermatomyositis (DM) was the most common subtype (73.4%). Fitzpatrick phototypes IV (59.4%) and III (37.5%) predominated. CDASI scores indicated mild dermatological activity in 60.9% of cases. Cluster analysis identified four patient groups with distinct clinical and serological profiles.
Conclusion
IIM have a complex disease expression. Recognizing its heterogeneities can enhance personalized treatment approaches.